Medicon Village launches an investor panel initiative to support companies in raising capital
Raising capital is a continuous challenge for growing companies, particularly within the life science sector, and strong connections to investors not only serve to provide necessary capital to fund future growth, but also support life science companies with important competences and networks to facilitate their access to market.
To address this need, Medicon Village is launching the Medicon Village Investor Panel (“MVIP”) together with corporate finance expert Markus Neuding, who is the former Vice President of Spotlight Group and current owner of Sedermera Corporate Finance.
"It is rare to meet a growing company that does not face the challenge of securing funding. This is a common issue across all growth industries but is particularly critical in life sciences, where high investment levels are required at various stages. By leveraging Markus Neuding’s expertise and his extensive network of investors, we believe that MVIP will become a valuable resource for Medicon Village members and Medicon Village alike," says Petter Hartman, CEO of Medicon Village Innovation.
MVIP will consist of at least five senior investors, with Markus Neuding as the permanent convening member, and will act as a recurring platform connecting the panel of qualified investors with validated life science companies. Selected companies will have the opportunity to present their business cases to the panel, after which the investors may choose to invest directly and/or their expertise, provide strategic guidance, introduce companies to their own networks, or offer constructive feedback on how to refine their investment proposition.
MVIP Structure:
- At least five senior investors, with Markus Neuding as the convener and permanent member.
- Regular meetings where selected companies present their ideas.
- Opportunity for investors to contribute capital, time, and expertise.
- Strategic advisory and feedback on pitches.
- Support in establishing relationships with other relevant investor networks.
"I am honored to contribute to Medicon Village’s mission by helping member companies secure the funding they need to grow and become the next life science success stories. Medicon Village is the largest and leading life science hub in the Nordic region and has provided a conducive environment for several renowned companies to grow and flourish. I am confident that MVIP will attract long-term investors committed to supporting the next generation of groundbreaking innovations," says Markus Neuding.
The inaugural MVIP meeting is tentatively scheduled for early autumn 2025. Companies interested in participating will receive further information on the application process in due course.
For more information, please read the full press release (in Swedish).